STOCK TITAN
  1. Home
  2. EARS

EARS Stock Price, News & Analysis

ears

Company Description

EARS (Nasdaq: ears) is a publicly traded company.

ears stock has gained 203.0% over the past year.

This page provides a comprehensive overview of ears stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
+202.99%
Performance 1 year
$0.0
Market Cap
0.0
Shares outstanding

EARS (ears) stock. Over the past 12 months, the stock has gained 203.0%.

Latest News

View All
-2.65%

Auris Medical Announces Launch of New Corporate Website

-0.63%

Auris Medical Announces Publication of Data from Preclinical Studies with Bentrio™ Nasal Spray in Prevention and Mitigation of SARS-CoV-2

clinical trial
-3.07%

Auris Medical to Develop KRAS-Targeting RNA Treatment for Colorectal Cancer as First Therapeutic Indication for OligoPhore™ Technology

0.00%

Auris Medical to Initiate Market Launch of Bentrio™ Nasal Spray in Germany

+8.73%

Auris Medical Announces Significant Inhibition of Tumor Growth with OligoPhore siRNA Targeting NF-κB in Murine Model of Adult T-Cell Leukemia / Lymphoma

+2.71%

Auris Medical Announces Acquisition of RNA Therapeutics Company and Plans for Strategic Repositioning

acquisition

EARS has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 5 with negative movement. Key topics include clinical trial, acquisition, covid-19, conferences. View all ears news →

SEC Filings

View All

No SEC filings available for ears.

Financial Highlights

View Full Financials
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months